Obbligazione Intl Bk Renewal & Dev 1.9% ( US459058DL43 ) in USD

Intl Bk Renewal & Dev

100 USD ⇌

Stati Uniti

US459058DL43 ( in USD )

1.9% per anno ( pagato 2 volte l'anno)

15/03/2019 - Obbligazione è scaduto

Prospetto opuscolo dell'obbligazione Intl Bk Recon & Develop US459058DL43 in USD 1.9%, scaduta

4 000 000 000 USD

Intl Bk Recon & Develop è una società specializzata nella ricostruzione e nello sviluppo di infrastrutture bancarie internazionali.

The Obbligazione issued by Intl Bk Renewal & Dev ( United States ) , in USD, with the ISIN code US459058DL43, pays a coupon of 1.9% per year.
The coupons are paid 2 times per year and the Obbligazione maturity is 15/03/2019

Final Terms dated January 13, 2014

International Bank for Reconstruction and Development

Issue of US$4,000,000,000 1.875 per cent. Fixed Rate Notes due March 15, 2019

under the
Global Debt Issuance Facility

Terms used herein shall be deemed to be defined as such for the purposes of the terms and conditions
(the "Conditions") set forth in the Prospectus dated May 28, 2008. This document constitutes the Final
Terms of the Notes described herein and must be read in conjunction with such Prospectus.
SUMMARY OF THE NOTES
1. Issuer:
International Bank for Reconstruction and Development
("IBRD")
2. (i) Series Number:
11030
(ii) Tranche Number:
1
3. Specified Currency or Currencies
United States Dollars ("US$")
(Condition 1(d)):
4. Aggregate Nominal Amount:

(i) Series:
US$4,000,000,000
(ii) Tranche:
US$4,000,000,000
5. (i) Issue Price:
99.688 per cent. of the Aggregate Nominal Amount
(ii) Net proceeds:
US$3,982,520,000
6. Specified Denominations
US$1,000 and integral multiples thereof
(Condition 1(b)):
7. Issue Date:
January 16, 2014
8. Maturity Date (Condition 6(a)):
March 15, 2019
9. Interest Basis (Condition 5):
1.875 per cent. Fixed Rate
(further particulars specified below)
10. Redemption/Payment Basis
Redemption at par
(Condition 6):
11. Change of Interest or
Not Applicable
Redemption/Payment Basis:
12. Call/Put Options (Condition 6):
None
13. Status of the Notes (Condition 3):
Unsecured and unsubordinated
14. Listing:
Luxembourg Stock Exchange
15. Method of distribution:
Syndicated

DC_LAN01:288727.2

PROVISIONS RELATING TO INTEREST (IF ANY) PAYABLE
16. Fixed Rate Note Provisions
Applicable
(Condition 5(a)):
(i)
Rate of Interest:
1.875 per cent. per annum payable semi-annually in arrear
(ii) Interest Payment Date(s):
March 15 and September 15 of each year, commencing March 15,
2014, to and including the Maturity Date
(iii) Fixed Coupon Amount:
US$9.38 per minimum Specified Denomination
(iv) Broken Amount
Initial Broken Amount of US$3.07 per minimum Specified
Denomination, payable on March 15, 2014
(v) Day Count Fraction
30/360
(Condition 5(l)):
(vi) Other terms relating to the
Not Applicable
method of calculating interest
for Fixed Rate Notes:
PROVISIONS RELATING TO REDEMPTION
17. Final Redemption Amount of each US$1,000 per minimum Specified Denomination
Note (Condition 6):
18. Early Redemption Amount
As set out in the Conditions
(Condition 6(c)):
GENERAL PROVISIONS APPLICABLE TO THE NOTES
19. Form of Notes (Condition 1(a)):
Fed Bookentry Notes:

Fed Bookentry Notes available on Issue Date
20. New Global Note:
No
21. Financial Centre(s) or other special New York
provisions relating to payment
dates (Condition 7(h)):
22. Governing law (Condition 14):
New York
23. Other final terms:
Not Applicable

-2-

DISTRIBUTION
24. (i) If syndicated, names of
Citigroup Global Markets Inc.:
US$911,750,000
Managers and underwriting
J.P. Morgan Securities plc:
US$911,750,000
commitments:
Nomura International plc:
US$911,750,000
RBC Capital Markets, LLC:
US$911,750,000
The Toronto-Dominion Bank:
US$103,000,000
Deutsche Bank AG, London Branch:
US$100,000,000
Credit Suisse Securities (Europe) Limited:
US$50,000,000
Merrill Lynch International:
US$40,000,000
Bank of Montreal, London Branch:
US$5,000,000
Barclays Bank PLC:
US$5,000,000
BNP Paribas:
US$5,000,000
CastleOak Securities, L.P.:
US$5,000,000
Daiwa Capital Markets Europe Limited:
US$5,000,000
FTN Financial Securities Corp:
US$5,000,000
Goldman Sachs International:
US$5,000,000
HSBC Securities (USA) Inc.:
US$5,000,000
Jefferies International Limited:
US$5,000,000
Incapital LLC:
US$5,000,000
Morgan Stanley & Co. International plc:
US$5,000,000
Skandinaviska Enskilda Banken AB (PUBL):
US$5,000,000
(ii) Stabilizing Manager(s) (if
Not Applicable
any):
25. If non-syndicated, name of Dealer: Not Applicable
26. Total commission and concession:
0.125 per cent of the Aggregate Nominal Amount
27. Additional selling restrictions:
Not Applicable
OPERATIONAL INFORMATION
28. ISIN Code:
US459058DL43
29. CUSIP:
459058DL4
30. Common Code:
101620514
31. Any clearing system(s) other than
Bookentry system of the Federal Reserve Banks; Euroclear
Euroclear Bank S.A./N.V.,
Bank S.A./N.V.; Clearstream Banking, société anonyme,
Clearstream Banking, société
anonyme and The Depository
Trust Company and the relevant
identification number(s):
32. Delivery:
Delivery against payment
33. Intended to be held in a manner
Not Applicable
which would allow Eurosystem
eligibility:
GENERAL INFORMATION
IBRD's most recently published Information Statement was issued on September 18, 2013.

-3-

LISTING APPLICATION

These Final Terms comprise the final terms required for the admission to the Official List of the
Luxembourg Stock Exchange and to trading on the Luxembourg Stock Exchange's regulated market of the
Notes described herein issued pursuant to the Global Debt Issuance Facility of International Bank for
Reconstruction and Development.

SUPPLEMENTAL U.S. FEDERAL INCOME TAX CONSIDERATIONS

United States Internal Revenue Service Circular 230 Notice: To ensure compliance with U.S. Internal
Revenue Service Circular 230, prospective investors are hereby notified that: (a) any discussion of U.S.
federal tax issues contained or referred to in this Final Terms or any document referred to herein is not
intended or written to be used, and cannot be used by prospective investors for the purpose of avoiding
penalties that may be imposed on them under the U.S. Internal Revenue Code; (b) such discussion is written
for use in connection with the promotion or marketing of the transactions or matters addressed herein; and (c)
prospective investors should seek advice based on their particular circumstances from an independent tax
advisor.

Information with Respect to Foreign Financial Assets. Owners of "specified foreign financial assets"
with an aggregate value in excess of $50,000 (and in some circumstances, a higher threshold) may be required
to file an information report with respect to such assets with their tax returns. "Specified foreign financial
assets" may include financial accounts maintained by foreign financial institutions (such as the Notes), as well
as the following, but only if they are not held in accounts maintained by financial institutions: (i) stocks and
securities issued by non-United States persons, (ii) financial instruments and contracts held for investment that
have non-United States issuers or counterparties, and (iii) interests in foreign entities. Holders are urged to
consult their tax advisors regarding the application of this legislation to their ownership of the Notes.

Medicare Tax. A U.S. holder that is an individual or estate, or a trust that does not fall into a special
class of trusts that is exempt from such tax, will be subject to a 3.8% tax on the lesser of (1) the U.S. holder's
"net investment income" for the relevant taxable year and (2) the excess of the U.S. holder's modified adjusted
gross income for the taxable year over a certain threshold (which in the case of individuals will be between
$125,000 and $250,000, depending on the individual's circumstances). A holder's net investment income will
generally include its gross interest income and its net gains from the disposition of Notes, unless such interest
payments or net gains are derived in the ordinary course of the conduct of a trade or business (other than a
trade or business that consists of certain passive or trading activities). If you are a U.S. holder that is an
individual, estate or trust, you are urged to consult your tax advisors regarding the applicability of the
Medicare tax to your income and gains in respect of your investment in the Notes.

-4-

RESPONSIBILITY
IBRD accepts responsibility for the information contained in these Final Terms.
Signed on behalf of IBRD:

By:
..........................................................

Name:
Title:

Duly authorized

-5-